FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082276 [Registered on: 13/03/2025] Trial Registered Prospectively
Last Modified On: 12/03/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Development and Validation of a Novel Screening Tool for Early Detection of Developmental and Mood Disorders in Children and Adolescents 
Scientific Title of Study   Development of a new screening tool for early diagnosis of developmental and mood disorders in children and adolescents 
Trial Acronym  Nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shreenivas Rachakonda 
Designation  Post Graduate, Paediatrics 
Affiliation  Saveetha Medical College and Hospital 
Address  Dept of Paediatrics, Saveetha Medical College and Hospital, Saveetha Nagar, Thandalam, Chennai Bengaluru, NH 48, Chennai, Tamil Nadu

Kancheepuram
TAMIL NADU
602105
India 
Phone  09008842152  
Fax    
Email  shreenivas.rachakonda30@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Lal DV 
Designation  Professor, Program Director Saveetha CDC, Paediatrics 
Affiliation  Saveetha Medical College and Hospital 
Address  Dept of Paediatrics, Saveetha Medical College and Hospital, Saveetha Nagar, Thandalam, Chennai Bengaluru, NH 48, Chennai, Tamil Nadu

Kancheepuram
TAMIL NADU
602105
India 
Phone  7299938038  
Fax    
Email  drlaldv@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Lal DV 
Designation  Professor, Program Director Saveetha CDC, Paediatrics 
Affiliation  Saveetha Medical College and Hospital 
Address  Dept of Paediatrics, Saveetha Medical College and Hospital, Saveetha Nagar, Thandalam, Chennai Bengaluru, NH 48, Chennai, Tamil Nadu

Kancheepuram
TAMIL NADU
602105
India 
Phone  7299938038  
Fax    
Email  drlaldv@gmail.com  
 
Source of Monetary or Material Support  
Saveetha Medical College Hospital, Saveetha Nagar, Thandalam, Kancheepuram district, Tamil Nadu 602105, India 
 
Primary Sponsor  
Name  Dr Shreenivas Rachakonda 
Address  Saveetha Medical College Hospital, Saveetha Nagar, Thandalam, Kancheepuram district, Tamil Nadu 602105, India 
Type of Sponsor  Other [SELF] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Shreenivas Rachakonda  Saveetha Medical College and Hospital  Dept of Paediatrics, Saveetha Medical College and Hospital, Saveetha Nagar, Thandalam, Chennai Bengaluru, NH 48, Chennai, Tamil Nadu
Kancheepuram
TAMIL NADU 
09008842152

shreenivas.rachakonda30@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Saveetha Medical College and Hospital Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  NORMAL 
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  NIL  NIL 
Comparator Agent  NIL  NIL 
 
Inclusion Criteria  
Age From  1.00 Month(s)
Age To  18.00 Year(s)
Gender  Both 
Details  1. Children aged 1 month to 18 years
2. Availability of a Primary Caregiver or Parent
3. Consent to Participate in the study and the follow – up process 
 
ExclusionCriteria 
Details  1. Children diagnosed Severe Neurological Disorders: Children with epilepsy with uncontrolled seizures, or neurodegenerative disorders that significantly impair communication or cooperation in screening assessments.
2. Children with acute medical illness at the time of screening: Children who are hospitalized or have a severe acute illness at the time of screening will be excluded to avoid confounding effects on behavioral assessment.
3. Children with a prior diagnosis with a fully established psychiatric disorder and undergoing intensive treatment: If a child is already diagnosed with a psychiatric disorder (e.g., schizophrenia, severe bipolar disorder, major depressive disorder) and is undergoing intensive psychiatric treatment (hospitalization, psychotherapy, or multiplepsychotropic medications), they may be excluded to prevent bias in validation.
4. Children with history of developmental regression due to organic causes: Children with documented progressive developmental regression due to metabolic or genetic syndromes that significantly impact cognitive and behavioral function.
5. Children with non-consent from Parent/Guardian 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
To develop and validate a novel screening tool for early detection of developmental, mood, and behavioral disorders in children and adolescents.  2 years 
 
Secondary Outcome  
Outcome  TimePoints 
Prevalence of Developmental, Mood, and Behavioral Disorders in the study population  2 years 
 
Target Sample Size   Total Sample Size="3300"
Sample Size from India="3300" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
The proposed research project aims to develop a novel screening tool for the early diagnosis of developmental and mood disorders in children and adolescents . Early detection of such disorders is crucial for timely intervention, which can significantly improve long-term outcomes for affected children. The screening tool will be designed to be comprehensive yet easy to administer, parent-reported measures to identify early signs of developmental delays and mood disturbances.

This project will involve several phases, starting with an extensive review of existing screening tools and current literature to identify gaps and areas for improvement. The next phase will focus on the design and development of the new tool, leveraging the latest advancements in developmental psychology and pediatric psychiatry. The tool will undergo rigorous validation through pilot studies involving diverse populations to ensure its accuracy, reliability, and cultural sensitivity.

Ultimately, the goal of this project is to create an effective, widely applicable screening tool that can be used by healthcare professionals and educators to facilitate early diagnosis and intervention. By identifying developmental and mood disorders at an earlier stage, the tool will help to provide children with the necessary support and resources to enhance their developmental trajectories and overall well-being.
 
Close